A Phase III Trial Evaluating Fruquintinib Efficacy and Safety in 3+ Line Colorectal Cancer Patients （FRESCO)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jin Li, PhD, MD
Fudan University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hutchison Medi Pharma Investigational Site
Hefei, Anhui, China
- Hutchison Medi Pharma Investigational Site
Beijing, Beijing Municipality, China
- Hutchison Medi Pharma Investigational Site
Guangzhou, Guangdong, China
- Hutchison Medi Pharma Investigational Site
Shenzhen, Guangdong, China
- Hutchison Medi Pharma Investigational Site
Liuzhou, Guangxi, China
- Hutchison Medi Pharma Investigational Site
Harbin, Heilongjiang, China
- Hutchison Medi Pharma Investigational Site
Changsha, Hunan, China
- Hutchison Medi Pharma Investigational Site
Changzhou, Jiangsu, China
- Hutchison Medi Pharma Investigational Site
Nanjing, Jiangsu, China
- Hutchison Medi Pharma Investigational Site
Nantong, Jiangsu, China
- Hutchison Medi Pharma Investigational Site
Xuzhou, Jiangsu, China
- Hutchison Medi Pharma Investigational Site
Changchun, Jilin, China
- Hutchison Medi Pharma Investigational Site
Qingdao, Shandong, China
- Hutchison Medi Pharma Investigational Site
Shanghai, Shanghai Municipality, China
- Hutchison Medi Pharma Investigational Site
Hangzhou, Zhejiang, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2014
- Primary completion
- 31 Jan 2017
- Completion
- 17 Jan 2017
- Last update posted
- 17 Feb 2020
- Registered enrollment
- 416
- Registry id
- NCT02314819
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.